Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
Isabelle Mahé, Céline Chapelle, Philippe Girard, Marc Carrier, Luis Jara‐Palomares, Charles Marc Samama, H. L. Helfer, Grigoris Gerotziafas, Silvy Laporte, Éric Vicaut, Patrick Mismetti, Patrick Mismetti, Isabelle Mahé, Isabelle Mahé, Silvy Laporte, Didier Mayeur, Giancarlo Agnelli, Cecilia Becattini, Manuel Monreal, Juan José López-Núñez, Peter Verhamme, Adam Torbicki, Sebastian Szmit, Marc Righini, Alexander T Cohen, Anthony Maraveyas, Menno Huisman, Frederikus A Klok, Kostas N Syrigos, Aristotelis Bamias, Cihan Ay, Marc Carrier, Grégoire Le Gal, Éric Vicaut
Topics & Concepts
MedicineVenous thromboembolismMajor bleedingPulmonary embolismMEDLINESurgeryIntensive care medicineClinical trialInternal medicineThrombosisRivaroxabanComplicationRisk assessmentCohort studyText miningRandomized controlled trialVenous Thromboembolism Diagnosis and ManagementHeparin-Induced Thrombocytopenia and ThrombosisCentral Venous Catheters and Hemodialysis